Reviews
Prasad has woven together a book that is rich in detail and brings to life compelling stories about both patients and the medicines that have helped them.
Book Details
Introduction
Part I. The Journey from Idea to Approval
Chapter 1. Leukemia and Lymphoma
Chapter 2. Chimeric Antigen Receptor (CAR)-T Cell Therapy
Chapter 3. Spinal Muscular Atrophy
Chapter 4. In Vivo Gene
Introduction
Part I. The Journey from Idea to Approval
Chapter 1. Leukemia and Lymphoma
Chapter 2. Chimeric Antigen Receptor (CAR)-T Cell Therapy
Chapter 3. Spinal Muscular Atrophy
Chapter 4. In Vivo Gene Therapy
Chapter 5. Sickle Cell Anemia
Chapter 6. Ex Vivo Gene-Modified Cell Therapy
Chapter 7. A Brief History of FDA Regulation
Chapter 8. The Path to Approval
Part II. Enabling the Next Wave Of Innovation
Chapter 9. Building Blocks
Chapter 10. Recognizing Value
Chapter 11. Financial and Human Capital Investments in Biotechnology
Chapter 12. Looking Forward
Epilogue. COVID-19
Acknowledgments
References
Index